TGF-BETA-POLYPEPTIDE

Patent europeic · EP4034170 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4034170
Numer da la dumonda
EP20878575
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
22-10-2020
Publitgà
03-08-2022
Concedì
11-02-2026
La protecziun finescha il pli tard
21-10-2040
Proxima taxa annuala scadenta
31-10-2026
Classas IPC
C12N 15/62 (2006.01)
C07K 14/71 (2006.01)
C07K 14/495 (2006.01)
A61P 37/00 (2006.01)
Prioritad
US 201962925227 P 23.10.2019
Dumonda PCT
PCT/US2020/056937 22.10.2020
Publicaziun PCT
WO2021/081258 29.04.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 13-03-2026

    Represchentant inscrit

    Representative
    Murgitroyd & Company, Geneva Rhone 8 Sàrl, Rue du Commerce 4, 1204 Genève

    Published in Swissreg on 13.03.2026

  2. 11-02-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.02.2026

Partidas

Possessur

Cue Biopharma, Inc.

40 Guest Street, Boston, MA 02135, US

Represchentant

Murgitroyd & Company

Geneva Rhone 8 Sàrl Rue du Commerce 4, 1204 Genève

Inventur

SEIDEL, III, Ronald D.

Cambridge, Massachusetts 02139, US

CHAPARRO, Rodolfo J.

Cambridge, Massachusetts 02139, US

ROSS, John F.

Cambridge, Massachusetts 02139, US

LOW, Chee Meng

Cambridge, Massachusetts 02139, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.